Versatile Co‐Engineering of Immunogenic Cell Death‐Primed Dead Tumor Cell Bodies With Tumor‐Activated MnO 2 for cGAS‐STING‐Potentiated Personalized Immunotherapy
Advanced Science · 2026-11 · 13 (61)
DOI: 10.1002/advs.77126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 12.08.2026. Verfasst von Bolun Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, P. R. China. Hauptthemen laut MEDLINE: Immunotherapy, Manganese Compounds, Oxides, Immunogenic Cell Death. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Central Guidance Fund for Local Science and Technology Development in Jiangxi Province, Young Talent Cultivation Program of Nanchang University.
Abstract (Originalsprache)
Immunogenic cell death (ICD)‐based whole‐cell personalized cancer immunotherapies present full tumor antigens but suffer from poor immunogenicity, early clearance, and a glutathione (GSH)‐rich immunosuppressive tumor microenvironment (TME). Here, we report a TME‐responsive immunotherapeutic platform, DTBEI@CS@MnO 2 , which integrates immunogenicity‐enhanced dead tumor cell bodies (DTBEI) with Mn 2 + ‐potentiated innate immunity. Tumor cells preloaded with indocyanine green (ICG) are sequentially functionalized with a chitosan (CS) interlayer followed by MnO 2 adsorption (CS@MnO 2 ) via electrostatic interactions. Upon near‐infrared laser irradiation, ICG‐mediated photodynamic/photothermal effect induces potent ICD, generating DTBEI. Within the acidic and GSH‐enriched TME, the CS@MnO 2 coating disassembles to release DTBEI and MnO 2 . DTBEI provides endogenous antigens and ICD‐associated danger signals, while MnO 2 is reduced by GSH to Mn 2 + . The resulting Mn 2 + amplifies DTBEI‐ and tumor‐derived deoxyribonucleic acid‐triggered cyclic GMP‐AMP synthase (cGAS)‐stimulator of interferon genes (STING) activation and downstream immune‐stimulatory effects, thereby synergistically promoting dendritic cell maturation, antigen cross‐presentation, and tumor‐specific T‐cell priming. Consequently, DTBEI@CS@MnO 2 elicits durable anti‐tumor immunity, effectively inhibiting tumor growth and suppressing recurrence and metastasis, while establishing T‐cell memory responses. Importantly, this strategy shows broad applicability in multiple tumor models, including CT26 colon cancer, 4T1 breast cancer, and B16F10 melanoma, while maintaining favorable biocompatibility. Overall, these findings highlight a materials‐based approach for personalized cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Nanchang University, Nanchang, P. R. China.
- State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, P. R. China.
ORCID-Profile: Xuan Lu, Ying Zhang, Yiqun Wan, Hao Wan
Förderung
- National Natural Science Foundation of China
- Central Guidance Fund for Local Science and Technology Development in Jiangxi Province
- Young Talent Cultivation Program of Nanchang University
- Natural Science Foundation of Jiangxi Province
- Research Project of State Key Laboratory of Food Science and Resources
Zitieren
APA
Xu, B., Lu, X., Wang, Y., Ji, H., Zhang, Y., Wan, Y., & Wan, H. (2026). Versatile Co‐Engineering of Immunogenic Cell Death‐Primed Dead Tumor Cell Bodies With Tumor‐Activated MnO 2 for cGAS‐STING‐Potentiated Personalized Immunotherapy. Advanced Science, 13(61). https://doi.org/10.1002/advs.77126
Vancouver
Xu B, Lu X, Wang Y, Ji H, Zhang Y, Wan Y, et al. Versatile Co‐Engineering of Immunogenic Cell Death‐Primed Dead Tumor Cell Bodies With Tumor‐Activated MnO 2 for cGAS‐STING‐Potentiated Personalized Immunotherapy. Advanced Science. 2026;13(61). doi:10.1002/advs.77126
BibTeX
@article{Xu2026,
author = {Xu, Bolun and Lu, Xuan and Wang, Yuquan and Ji, Haihua and Zhang, Ying and Wan, Yiqun and Wan, Hao},
title = {Versatile Co‐Engineering of Immunogenic Cell Death‐Primed Dead Tumor Cell Bodies With Tumor‐Activated MnO 2 for cGAS‐STING‐Potentiated Personalized Immunotherapy},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {61},
doi = {10.1002/advs.77126}
}
EUVIMED